Par Pharmaceutical is categorized under Pharmaceutical Manufacturing Plant Construction in Irvine, CA and active since 2003.
Par Pharmaceutical was established in 2003, and today employs 1 to 4, earning $20.000.000 to $49.9999.999 per year. This is a Pharmaceutical Manufacturing Plant Construction business, which does work in the B2B market, and is classified as a Pharmaceutical Manufacturing Plant Construction, under code number 4242101 by the NAICS.
If you are seeking more information, feel free to contact Paul V Campanelli at the company’s single location by writing to 9601 Jeronimo Road, Irvine, California CA 92618 or by phoning (949) 587-1848. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Par Pharmaceutical |
| Contact Person: | Paul V Campanelli |
| Address: | 9601 Jeronimo Road, Irvine, California 92618 |
| Phone Number: | (949) 587-1848 |
| Annual Revenue (USD): | $20.000.000 to $49.9999.999 |
| Founded: | 2003 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Pharmaceutical Manufacturing Plant Construction |
| SIC Code: | 1541 |
| NAICS Code: | 4242101 |
| Share This Business: |
Par Pharmaceutical was started in 2003 to provide professional Pharmaceutical Manufacturing Plant Construction under the SIC code 1541 and NAICS code 4242101. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $20.000.000 to $49.9999.999 per annum.
Feel free to contact Paul V Campanelli for inquiries that concern Par Pharmaceutical by calling the company number (949) 587-1848, as your correspondence is most welcome. Additionally, the physical location of the single location of Par Pharmaceutical can be found at the coordinates 33.64858,-117.71615 as well as the street address 9601 Jeronimo Road in Irvine, California 92618.
For its online presence, you may visit Par Pharmaceutical’s website at and engage with its social media outlets through on Twitter and on Facebook.